Navigation Links
Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter

BATESVILLE, Ind., Feb. 3 /PRNewswire-FirstCall/ --

  • Revenue of $355 million grew 1.1 percent versus prior year

  • Reported diluted earnings per share were $0.31 compared to adjusted earnings per share of $0.25 and reported earnings per share of $0.23 in the prior year

  • Gross margin improved 470 basis points versus the prior year

  • Company updates annual guidance for fiscal year 2010:  Reaffirms revenue of $1.45 to $1.50 billion and updates earnings to $1.24 to $1.36 per diluted share, excluding special items

Hill-Rom Holdings, Inc. (NYSE: HRC), announced solid financial results for its fiscal first quarter ended December 31, 2009, and updated its outlook for the full year.   Net income grew 39 percent to $19.8 million from $14.2 million in the prior year.  Earnings per diluted share of $0.31 increased 35 percent from $0.23 per diluted share in the same period of the prior year.  On an adjusted basis, earnings per diluted share of $0.31 increased 24 percent from $0.25 in the prior year.  The improved financial performance was the result of continued gross margin expansion in all of Hill-Rom's major business units.  

Hill-Rom's total revenue of $355.3 million increased 1.1 percent compared to the first quarter of last year. On a constant currency basis, revenue decreased 1.7 percent.  Domestic sales declined 3.6 percent to $244.7 million, while international sales increased 13.1 percent to $110.6 million.  Excluding the impact of foreign currency, Hill-Rom's international sales increased 3.3 percent.

Management Comments

"I am pleased with the operating improvements that we delivered during the first quarter," stated John J. Greisch, president and CEO of Hill-Rom.  "We have seen demand levels stabilize over the past several quarters, and despite a challenging macro-economic environment, we achieved solid earnings improvement through margin expansion across all of our major business units.  Our improved margins have enabled us to increase investments in new product development and sales channels, while accelerating earnings."  

Other first quarter revenue highlights regarding Hill-Rom business segments include:

  • North America Acute Care.  North America Acute Care revenue declined $5.6 million, or 2.8 percent, to $197.9 million versus the prior year.  Capital sales decreased 7.2 percent, or $10.1 million, due to the prior year divestiture of certain non-strategic information technology product lines and the impact of lower hospital capital purchasing.  Rental revenue increased $4.5 million, or 7.1 percent, driven by growth of therapy rental products and the impact of H1N1-related influenza.

  • International and Surgical.  International and Surgical revenues increased 8.6 percent, or $8.5 million, to $107.4 million.  On a constant currency basis, revenues were essentially flat.  As reported, capital sales and rental revenue grew 7.6 and 15.4 percent, respectively.

  • North America Post-Acute Care.  North America Post-Acute Care revenue grew 4.4 percent to $52.6 million.  Capital sales revenue increased 6.4 percent, while rental revenue grew 3.8 percent.  Growth in this segment was primarily driven by respiratory care products.

Other First Quarter Financial and Operational Highlights

  • During the first quarter, Hill-Rom launched its Advanta™ 2 bed for use in medical-surgical areas of hospitals and alternate care facilities.  The new bed brings together ease of use with key safety features and the flexibility to use a variety of care surfaces as needed.  Commercial sales are expected to commence in the second quarter.

  • The company successfully launched the Hill-Rom® P400 Therapy Surface for extended care and home care customers in December.  This innovative product incorporates Self Adjusting Alternating Low Pressure (SAALP™) technology into a mattress replacement system to provide superior resident comfort and optimized continuous pressure ulcer therapy.  

  • In November, Hill-Rom announced a joint venture with Encompass Group LLC to provide hospitals with a broader range of replacement mattress systems for both Hill-Rom's and competitors' bed frames.  This joint venture will expand Hill-Rom's portfolio of replacement solutions for hospital customers.

Please see the attached schedules for additional information, including reconciliations of earnings in accordance with U.S. generally accepted accounting principles ("GAAP") to as adjusted income and earnings per share, condensed financial information, summary balance sheet information and segment sales summaries.  

For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended December 31, 2009, which will be filed later this week.

Financial Guidance Summary for 2010

The Company updated full year 2010 financial guidance as follows.  Hill-Rom is reaffirming reported sales guidance of $1.45 to $1.50 billion. This represents an increase of approximately 4 to 8 percent compared to 2009, including a currency benefit of approximately 1 percent for the full year.  The Company is increasing adjusted earnings guidance to $1.24 to $1.36 per diluted share.  This compares to the company's previous guidance of $1.20 to $1.36 per share.  On a reported basis, earnings per diluted share are expected to be $1.34 to $1.46, including a non-recurring tax benefit of $0.10 per share associated with a favorable tax audit resolution during the second quarter. Cash Flow from Operations for the full year is expected to be in the guidance range of $146 to $159 million.

Hill-Rom Holdings, Inc. provides earnings per share results and guidance on an adjusted basis because the company's management believes that the presentation provides useful information to investors.  These measures exclude strategic developments, undetermined special charges and the impact of significant litigation. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the company's reported operations for a period. Often, prospective quantification of such items is not feasible.  Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Additional assumptions and discussion will be provided during the Company's conference call to be held tomorrow morning.  Information to access the webcast is provided below.

Conference Call Replay and Webcast

The company will sponsor a conference call and webcast for the investing public at 8:00 a.m. EST, 7:00 a.m. CST, on Thursday, February 4, 2010.  The webcast is available at or and will be archived on the company's website for those who are unable to listen to the live webcast. A replay of the call is also available through February 12, 2010 at 888-203-1112 (719-457-0820 International). Code 2428159 is needed to access the replay.


Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom…enhancing outcomes for patients and their caregivers.

Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections.  The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology.  The absence of such terms, however, does not mean that the statement is not forward-looking.  It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements.  Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, impacts of healthcare reform, compliance with federal healthcare programs, collections of accounts receivable, compliance with FDA regulations, antitrust litigation, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, adverse consequences resulting from the spin-off of the funeral services business, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, liquidity of auction rate securities, and certain tax-related matters.  For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's previously filed Annual Report on Form 10-K for the period ended September 30, 2009, and the Quarterly Report on Form 10-Q for the quarter ended December 31, 2009, which will be filed later this week.  The Company assumes no obligation to update or revise any forward-looking statements.

                               Hill-Rom Holdings, Inc.             
                  Condensed Consolidated Statement of Earnings   
               (Dollars in millions except share and per share data)
                                  Q1 2010    Q1 2009  
                                 ---------  --------- 
    Net revenues                                      
      Capital sales                 $231.6     $236.0 
      Rental revenues                123.7      115.6 
                                     -----      ----- 
        Total revenues               355.3      351.6 
    Cost of revenues                                  
      Cost of goods sold             130.5      146.5 
      Rental expenses                 54.0       52.6 
                                      ----       ---- 
        Total cost of revenues       184.5      199.1 
    Gross profit                                      
      Capital sales                  101.1       89.5 
      Rental revenues                 69.7       63.0 
                                      ----       ---- 
        Total gross profit           170.8      152.5 
      As a percentage of sales        48.1%      43.4%
    Research and development                          
     expenses                         14.9       13.3 
    Selling and administrative                        
     expenses                        121.6      116.2 
                                     -----      ----- 
    Operating profit                  34.3       23.0 
    Other income/(expense), net       (1.6)      (2.0)
    Income tax expense                12.8        6.8
                                      ----       ---- 
    Net income                        19.9       14.2 
      Less:  Net income attributable 
       to noncontrolling interest      0.1          - 
                                       ---        --- 
    Net income attributable to                        
     common shareholders             $19.8      $14.2 
                                     =====      ===== 
    Diluted earnings per share:                       
      Earnings per share             $0.31      $0.23 
    Average common shares                             
     outstanding - diluted                            
     (thousands)                    63,205     62,808 
    Dividends per common share     $0.1025    $0.1025 
                               Hill-Rom Holdings, Inc.                       
                            Revenues - Constant Currency                     
                               (Dollars in millions)                         
                           Q1 2010  Y/Y Foreign  Q1 2010  Q1 2009  Adj/Actual
                            Actual    Exchange  Adjusted   Actual   % Change
                            ------    --------  --------   ------   --------
      Capital sales         $231.6        $7.8    $223.8   $236.0      -5.2%
      Rental revenues        123.7         1.8     121.9    115.6       5.4%
                             -----         ---     -----    -----       --- 
    Total                   $355.3        $9.6    $345.7   $351.6      -1.7%
                            ======        ====    ======   ======      ==== 
      Acute Care            $197.9        $1.3    $196.6   $203.5      -3.4%
      Post Acute Care         52.6           -      52.6     50.4       4.4%
      International and                                                     
       Surgical              107.4         8.3      99.1     98.9       0.2%
      Eliminations            (2.6)          -      (2.6)    (1.2)    116.7%
                              ----         ---      ----     ----     ----- 
    Total                   $355.3        $9.6    $345.7   $351.6      -1.7%
                            ======        ====    ======   ======      ==== 

Non-GAAP Financial Disclosures and Reconciliations

While Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

                             Hill-Rom Holdings, Inc.                        
                       Reconciliation: Earnings Per Share                   
                   (Dollars in millions except per share data)              
                                       Q1 2010                Q1 2009       
                               ---------------------- -----------------------
                                       Income Diluted         Income  Diluted
                               Pre-tax  Taxes   EPS   Pre-tax  Taxes    EPS  
                               -------  -----   ---   -------  -----    ---  
    GAAP Earnings                $32.7  $12.8   $0.31   $21.0   $6.8   $0.23
      Effect of Liko inventory                                              
       valuation                     -      -       -     1.9    0.5    0.02
      Liko acquisition                                                      
       integration charges           -      -       -     0.3    0.1       -
                                   ---    ---     ---     ---    ---     ---
    Adjusted Earnings            $32.7  $12.8   $0.31   $23.2   $7.4   $0.25
                                 =====  =====   =====   =====   ====   =====
                              Hill-Rom Holdings, Inc.                     
                       Condensed Consolidated Balance Sheet              
                              (Dollars in millions)                      
                                      12/31/2009 9/30/2009 12/31/2008
                                      ---------- --------- ----------
    Current Assets                                                   
      Cash and cash equivalents           $123.8    $170.6      $49.5
      Trade accounts receivable, net                                 
       of allowances                       345.4     346.6      348.8
      Inventories                           94.7      92.0      127.3
      Other current assets                  91.6      85.9       50.1
                                            ----      ----       ----
        Total current assets               655.5     695.1      575.7
    Equipment leased to others, net        150.1     154.8      164.3
    Property, net                          113.7     117.6      124.9
    Goodwill                                80.7      73.1      539.1
    Other assets                           196.6     192.0      221.4
                                           -----     -----      -----
    Total Assets                        $1,196.6  $1,232.6   $1,625.4
                                        ========  ========   ========
    Current Liabilities                                              
      Trade accounts payable               $71.5     $81.3      $80.7
      Short-term borrowings                 58.9     102.2      122.0
      Other current liabilities            154.1     160.8      144.3
                                           -----     -----      -----
        Total current liabilities          284.5     344.3      347.0
    Long-term debt                          99.4      99.7      100.8
    Other long-term liabilities            179.5     179.3      115.4
                                           -----     -----      -----
    Total Liabilities                      563.4     623.3      563.2
                                           -----     -----      -----
    Noncontrolling interest                  7.5         -          -
    Shareholders' Equity                   625.7     609.3    1,062.2
                                           -----     -----    -------
    Total Liabilities,                                               
     Noncontrolling Interest                                         
      and Shareholders' Equity          $1,196.6  $1,232.6   $1,625.4
                                        ========  ========   ========
                              Hill-Rom Holdings, Inc.                         
                       Consolidated Statements of Cash Flows                  
                               (Dollars in millions)                          
                                                             Q1 2010  Q1 2009 
                                                             -------  ------- 
    Operating Activities                                                      
      Net income                                               $19.9    $14.2 
      Adjustments to reconcile net income to                                  
       net cash flows from operating activities:                
        Depreciation and amortization                           24.4     26.1 
        Investment loss                                            -      0.2 
        Provision for deferred income taxes                     (5.4)    (3.2)
        Loss on disposal of property,                                         
         equipment leased to others,                                          
               intangible assets and impairments                 0.8      0.6 
        Stock compensation                                       3.6      2.4 
        Change in working capital excluding cash, current                     
         investments, current debt, prepaid pension costs, 
         acquisitions and dispositions 
              Trade accounts receivable                          4.2     58.8 
              Inventories                                       (2.2)   (11.6)
              Other current assets                              (4.4)    (5.7)
              Trade accounts payable                           (11.4)   (24.2)
              Accrued expenses and other liabilities            (7.4)   (29.0)
        Other, net                                              (0.5)     6.3 
                                                                ----      --- 
    Net cash provided by                                                      
     operating activities                                       21.6     34.9 
                                                                ----     ---- 
    Investing Activities                                                      
      Capital expenditures and                                                
       purchase of intangibles                                 (11.6)   (13.6)
      Proceeds on sales of property and                                       
       equipment leased to others                                0.1      0.5 
      Investment in/acquisitions of businesses,                               
       net of cash acquired                                     (7.1)  (187.2)
      Proceeds on investment sales/maturities                    0.5      1.3 
                                                                 ---      --- 
    Net cash used in                                                          
     investing activities                                      (18.1)  (199.0)
                                                               -----   ------ 
    Financing Activities                                                      
      Change in short-term debt                                  1.6        - 
      Payment on revolver                                      (45.0)       - 
      Payment of cash dividends                                 (6.4)    (6.4)
      Proceeds on exercise of options                            0.2        - 
      Proceeds from stock issuance                               0.7        - 
      Treasury stock acquired                                   (0.8)    (0.5)
                                                                ----     ---- 
    Net cash used in                                                          
     financing activities                                      (49.7)    (6.9)
                                                               -----     ---- 
    Effect of exchange rate                                                   
     changes on cash                                            (0.6)    (1.2)
                                                                ----     ---- 
    Total Cash Flows                                           (46.8)  (172.2)
    Cash and Cash Equivalents:                                                
      At beginning of period                                   170.6    221.7 
                                                               -----    ----- 
      At end of period                                        $123.8    $49.5 
                                                              ======    ===== 

SOURCE Hill-Rom Holdings, Inc.



SOURCE Hill-Rom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
2. Hill-Rom Announces Corporate Governance Enhancements
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
4. Hill-Rom and Encompass Group Form Joint Venture
5. Hill-Rom to Host Investors Conference in New York City
6. Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies
7. Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
(Date:11/26/2015)... PUNE, India , November ... --> ... / personal emergency response system ... grow steadily for 5 years ... growing region expected to see ...
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
Breaking Medicine Technology:
(Date:11/26/2015)... , ... November 26, 2015 , ... ... abuse located in central Michigan, have come together on Thanksgiving Day to share ... video, available for viewing on the Serenity Point YouTube channel, patients displayed what ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they ... to buy during the Black Friday and Cyber Monday massage chair sales ... the Internet high and low to find the best massage chair deals, they can ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... Ashburn, VA (PRWEB) , ... November 26, 2015 ... ... Planners, an American Express Travel Representative. As a franchise owner, Somu now offers ... range of cruise, destination wedding packages, private cruise sales, as well as, cabin ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
Breaking Medicine News(10 mins):